CHEK2 GENE MUTATION
Clinical trials for CHEK2 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new CHEK2 GENE MUTATION trials appear
Sign up with your email to follow new studies for CHEK2 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope: targeted drug olaparib shows promise for Hard-to-Treat breast cancer
Disease control OngoingThis study tests a drug called olaparib in people with metastatic breast cancer that has spread beyond the breast. Participants must have a specific genetic change in their tumor that may make it sensitive to this drug. The goal is to see if olaparib can shrink tumors or slow can…
Matched conditions: CHEK2 GENE MUTATION
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
New drug combo targets prostate cancer in understudied groups
Disease control TerminatedThis study was designed to test a combination of two drugs, niraparib and abiraterone plus prednisone, in Hispanic/Latino and Black patients with a specific type of metastatic prostate cancer that has certain gene mutations. The goal was to see if the treatment could lower PSA le…
Matched conditions: CHEK2 GENE MUTATION
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated May 22, 2026 14:03 UTC